WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

REVIEW: “RESISTING HIV VIRUS THROUGH CCR5 DELTA 32 GENETIC MUTATION”

Shubham Ghuge*, Pranali Hatvar and Dr. Gajanan Sanap

ABSTRACT

HIV was originally discovered as the causative agent of AIDS, numerous anticipated to find a vaccine within a many times. This has still proven to be fugitive; it has been roughly 30 times since HIV was first discovered, and a suitable vaccine is still not in effect. HIV- 1 can persist in a idle form in resting memory CD4 cells and macrophages carrying an integrated dupe of the HIV genome. Because of the presence of these stable force cells, eradication by antiretroviral remedy is doubtful and in order to achieve eradication, indispensable treatment options are needed. Stem cell transplantation has been considered preliminarily to effect the clinical course of HIV- infection but in practice eradication or contagion control wasn't attainable. still, variations of stem cell transplantation using natural or artificial resistant cell sources, combination with new ways of gene editing or generating cytotoxic anti HIV effector cells have stimulated this field of HIV cell remedy mainly. Then, we look back on 30 times of stem cell remedy in HIV cases and bandy utmost recent developments in this direction The first chemokine was discovered in 1977 and since also a large super family of chemokines has been linked. Chemokines are small proteins with several functions including vulnerable surveillance and vulnerable cell reclamation. The goods of these chemokines are intermediated by their G- protein- coupled receptors GPCR's). Chemokines are classified as C, CC, CXC and CX3C depending on the structure and number of cysteine remainders. Chemokine receptors are set up on cell shells and promote cellular migration by chemotaxis. The CC chemokine receptor 5(CCR5) is used by the mortal immunodeficiency contagion(HIV) to infect cells. Strategies that target mortal CCR5 are thus being developed to help and treat HIV infection. Antiviral strategies that target a host element necessary for viral replication may be prognosticated to intrude with the function of that element and may thus negatively affect the host.

Keywords: AIDS, CCR5, chemokine.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More